Accelerating Severe ME/CFS Research
August is Severe ME/CFS Awareness Month–a time to reflect on the toll this disease takes
August 6, 2026
August is Severe ME/CFS Awareness Month–a time to reflect on the toll this disease takes
Dr. Rob Wüst, physiology professor at the Vrije de Universiteit (Netherlands) and winner of a
Dr. David Esteban is a professor of biology at Vassar College. He specializes in understanding
This quarter’s summaries highlight several studies examining the biological mechanisms of ME/CFS and Long Covid,
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit
Solve Ramsay Research Grant winner Dr. Lubov Nathanson and her team at Nova Southeastern University have been
Two recently published studies funded by Solve are pointing to gastrointestinal dysfunction as a key
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS